Integrity Alliance LLC. Sells 6,420 Shares of CVS Health Corporation $CVS

Integrity Alliance LLC. trimmed its position in shares of CVS Health Corporation (NYSE:CVS) by 50.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,373 shares of the pharmacy operator’s stock after selling 6,420 shares during the period. Integrity Alliance LLC.’s holdings in CVS Health were worth $440,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the company. AMG National Trust Bank grew its holdings in CVS Health by 1.1% during the 2nd quarter. AMG National Trust Bank now owns 110,770 shares of the pharmacy operator’s stock valued at $7,641,000 after purchasing an additional 1,258 shares during the last quarter. Simon Quick Advisors LLC grew its holdings in CVS Health by 117.0% during the 2nd quarter. Simon Quick Advisors LLC now owns 17,388 shares of the pharmacy operator’s stock valued at $1,199,000 after purchasing an additional 9,374 shares during the last quarter. Strs Ohio grew its stake in CVS Health by 1.7% in the 2nd quarter. Strs Ohio now owns 837,532 shares of the pharmacy operator’s stock worth $57,773,000 after acquiring an additional 14,278 shares in the last quarter. Impact Partnership Wealth LLC bought a new position in CVS Health in the 2nd quarter worth about $573,000. Finally, Amalgamated Bank grew its stake in CVS Health by 0.4% in the 2nd quarter. Amalgamated Bank now owns 245,703 shares of the pharmacy operator’s stock worth $16,949,000 after acquiring an additional 1,049 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.22% of the stock is owned by insiders.

CVS Health Price Performance

NYSE CVS opened at $78.13 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. The firm’s 50 day moving average price is $76.49 and its 200-day moving average price is $69.04. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $85.15. The company has a market cap of $99.18 billion, a PE ratio of 205.61, a P/E/G ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same period last year, the firm earned $1.09 earnings per share. The company’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. CVS Health’s dividend payout ratio is presently 700.00%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Wall Street Zen downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday. Barclays upped their target price on shares of CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Mizuho upped their target price on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Finally, Bernstein Bank dropped their target price on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research note on Wednesday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $87.64.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.